Close Menu

OGI

NEW YORK (GenomeWeb News) – Researchers and clinicians around the globe who are looking for a genetic basis for any number of rare diseases have a new resource to turn to — a web portal for genetic and phenotypic information on rare diseases developed through an international collaboration and fu

NEW YORK (GenomeWeb News) – The government of Ontario recently announced about C$7 million (US$6.7 million) in new funding for four large-scale genomics projects.

NEW YORK (GenomeWeb News) – The Ontario Genomics Institute said today that it has launched a new division to support businesses seeking to capitalize on opportunities in the life sciences.

NEW YORK (GenomeWeb News) – The Ontario Genomics Institute said today that it has provided funding to Tissue Regeneration Therapeutics (TRT), a company developing umbilical stem cell-based treatments for a range of diseases, that will support 'omics-based research projects.

NEW YORK (GenomeWeb News) – The Ontario Genomics Institute today said that is providing $100,000 through its Pre-commercialization Business Development Fund (PBDF) to the University of Toronto to support its Mammalian Membrane Two-Hybrid (MaMTH) project, which seeks to develop and commercialize a

Researchers at the University of Toronto have won a CA$50,000 ($49,200) grant from the Ontario Genomics Institute to develop software to identify disease-causing mutations in DNA sequence data.

NEW YORK (GenomeWeb News) –The Ontario Genomics Institute said today that it has awarded C$200,000 ($196,000) in new funding to four high-impact, high-risk genomics research projects.

The Centre for Applied Genomics (TCAG) at the Hospital for Sick Children in Toronto has reeled in C$5.1 million (US$5 million) from the Ontario Genomics Institute to support its operations, OGI said today.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.